The Mexican-inspired street food joint has shared a picture of the latest offering on Instagram
An Indian government-backed Covid-19 vaccine showed it was safe and triggered immune responses during an ongoing early-stage trial, the company involved in the study said in a statement on Wednesday.
Also read: India 'likely to emerge' as country with highest Covid-19 tally
Bharat Biotech, the private company developing Covaxin with the government-run Indian Council of Medical Research (ICMR), said: "Covaxin demonstrated acceptable safety profile and high immune response. . . No serious (grade 3-4) adverse events were reported."
Phase II and Phase III clinical trials are underway.
The company earlier this month sought emergency-use authorisation from the Indian drug regulator for its Covid-19 vaccine to help achieve its plan to launch COVAXIN by the second quarter of 2021.
India has the world's second-highest caseload of coronavirus behind the United States, and it is looking to deploy its vast election machinery to deliver 600 million doses of Covid-19 vaccines to the most vulnerable people in the next six to eight months.
The Mexican-inspired street food joint has shared a picture of the latest offering on Instagram
Australia ended Day Three with 296 runs lead
Chelsea have reportedly joined the race with Manchester United for the Brazilian
23-year-old Alejandro Núñez Vicente's revised seat design was displayed at Aircraft Interiors Expo in Germany's Hamburg
The charges stem from his treatment of sensitive government materials that he took with him when he left the White House in January 2021
It will be a career-first Grand Slam title match in doubles for Fernandez, the 2021 U.S. Open runner-up
Here's a look at the charges, the special counsel's investigation and how Trump's case differs from those of other politicians known to be in possession of classified documents
Rahane and Thakur hit half-centuries in India's first innings total of 296